glucantime

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Infan Industria Quimica Farmaceutica Nacional

Conditions

Drug Side EffectLeishmaniasisLeishmaniasis; American, Cutaneous

Phase 2

Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil

CompletedNCT00004755

National Institute of Allergy and Infectious Diseases (NIAID)Leishmaniasis

Start: 1995-09-30Target: 375Updated: 2005-06-24

Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

Infan Industria Quimica Farmaceutica NacionalDrug Side Effect, Leishmaniasis; American, Cutaneous

Start: 2021-05-31End: 2024-07-31Target: 52Updated: 2020-03-19